Edition:
United Kingdom

Akcea Therapeutics Inc (AKCA.OQ)

AKCA.OQ on NASDAQ Stock Exchange Global Select Market

23.09USD
18 May 2018
Change (% chg)

$0.16 (+0.70%)
Prev Close
$22.93
Open
$23.02
Day's High
$23.18
Day's Low
$22.48
Volume
71,933
Avg. Vol
105,590
52-wk High
$33.86
52-wk Low
$8.10

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 17.11 -0.445
FY 2017 Dec '17 18.04 -0.349
Sep '17 13.45 -0.263
Jun '17 14.13 -0.414
Mar '17 6.09 -2.211
FY 2016 Dec '16 0.00 -1.171
Sep '16 0.00 -0.686
Jun '16 0.00 -0.471
Mar '16 0.00 -0.552
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 4 12.56 15.73 7.50 --
Quarter Ending Sep-18 4 23.54 37.40 14.78 --
Year Ending Dec-18 4 105.08 153.00 73.36 --
Year Ending Dec-19 4 443.76 874.00 142.13 --
Earnings (per share)
Quarter Ending Jun-18 3 -1.20 -0.46 -2.48 --
Quarter Ending Sep-18 3 -0.59 -0.45 -0.77 --
Year Ending Dec-18 3 -2.64 -1.55 -3.98 --
Year Ending Dec-19 4 0.30 4.95 -1.52 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.95 32.75
P/E High - Last 5 Yrs. -- 40.70 45.73
P/E Low - Last 5 Yrs. -- 23.63 24.23
Beta -- 0.89 0.88
Price to Sales (TTM) 78.42 3.94 5.71
Price to Book (MRQ) -- 4.81 5.37
Price to Tangible Book (MRQ) -- 5.61 6.94
Price to Cash Flow (TTM) -- 22.91 23.33
% Owned Institutions 10.29 1.21 2.16

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.47 5.32
Payout Ratio(TTM) -- 45.35 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.69 9.21
Sales (TTM) vs TTM 1 Yr. Ago -- 4.83 5.69
Sales - 5 Yr. Growth Rate -- 10.08 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago 12.27 16.38 19.38
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.87 10.77
Capital Spending - 5 Yr. Growth Rate -- 15.52 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.12 2.19
Current Ratio (MRQ) 1.78 2.90 2.98
LT Debt to Equity (MRQ) -- 9.88 12.17
Total Debt to Equity (MRQ) -- 13.86 16.44
Interest Coverage (TTM) -- 35.89 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -142.68 54.81 54.45
Gross Margin - 5 Yr. Avg. -- 52.15 52.21
EBITD Margin (TTM) -525.72 -- --
EBITD - 5 Yr. Avg -- 18.57 10.96
Operating Margin (TTM) -526.50 14.36 4.73
Operating Margin - 5 Yr. Avg. -- 14.52 6.40
Pre-Tax Margin (TTM) -530.85 14.82 5.57
Pre-Tax Margin - 5 Yr. Avg. -- 14.90 6.81
Net Profit Margin (TTM) -530.85 11.07 1.87
Net Profit Margin - 5 Yr. Avg. -- 11.20 3.09
Effective Tax Rate (TTM) -- 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.42 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 912,500 938,135,892 847,064,414
Net Income/Employee (TTM) -4,843,962 110,374,948 99,643,698
Receivable Turnover (TTM) -- 5.63 5.78
Inventory Turnover (TTM) -- 2.59 3.35
Asset Turnover (TTM) -- 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.40 10.95
Return on Assets - 5 Yr. Avg. -- 12.91 12.32
Return on Investment (TTM) -- 14.84 14.38
Return on Investment - 5 Yr. Avg. -- 16.88 16.11
Return on Equity (TTM) -- 16.34 16.07
Return on Equity - 5 Yr. Avg. -- 17.98 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -35.48 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Akcea Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 28.43 24.01 96 23
13 Week -- -- -- 35
26 Week -- -- -- 29
52 Week -- -- -- 12
YTD -- -- -- 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 24.23%
# of Holders: 92
Total Shares Held: 20,743,441
3 Mo. Net Change: 1,114,399
# New Positions: 13
# Closed Positions: 11
# Increased Positions: 38
# Reduced Positions: 41
# Net Buyers: -3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.